Edition:
United States

NeuroMetrix Inc (NURO.OQ)

NURO.OQ on NASDAQ Stock Exchange Capital Market

1.73USD
2:21pm EST
Change (% chg)

$0.01 (+0.58%)
Prev Close
$1.72
Open
$1.76
Day's High
$1.76
Day's Low
$1.68
Volume
2,505
Avg. Vol
18,601
52-wk High
$8.08
52-wk Low
$1.45

Latest Key Developments (Source: Significant Developments)

NeuroMetrix files for resale of up to 2.7 mln shares of its stock‍​
Tuesday, 8 Aug 2017 04:46pm EDT 

Aug 9 (Reuters) - NeuroMetrix Inc -:NeuroMetrix files for resale of up to 2.7 million shares of co's common stock issuable upon conversion of shares of series F preferred stock - sec filing‍​.  Full Article

Neurometrix announces DPNCheck distribution agreement with Fukuda Denshi in Japan
Thursday, 3 Aug 2017 10:13am EDT 

Aug 3 (Reuters) - Neurometrix Inc : :Neurometrix announces DPNCheck distribution agreement with Fukuda Denshi in Japan.  Full Article

NeuroMetrix reports Q2 2017 financial results
Thursday, 20 Jul 2017 07:00am EDT 

July 20 (Reuters) - Neurometrix Inc :Q2 revenue rose 63 percent to $4.3 million.NeuroMetrix Inc - loss from operations was $3.4 million in Q2 2017 versus $4.2 million in Q2 2016.  Full Article

Neurometrix announces $7.0 mln private placement of preferred stock
Monday, 10 Jul 2017 09:11pm EDT 

July 10 (Reuters) - Neurometrix Inc :Neurometrix announces $7.0 million private placement of preferred stock.Neurometrix - proceeds of offering will be used for commercialization of quell in united states.Neurometrix - purchase agreement connection with private placement of 7,000 shares of series f convertible preferred stock at price of $1,000 per share.  Full Article

NeuroMetrix announces one-for-eight reverse stock split
Thursday, 11 May 2017 11:45am EDT 

May 11 (Reuters) - NeuroMetrix Inc ::NeuroMetrix announces one-for-eight reverse split.Announced a one-for-eight reverse split of its common stock effective as of Thursday, May 11, 2017.Trading of co's common stock on NASDAQ Capital Market will continue, on a split-adjusted basis, with opening of markets on May 12, 2017.  Full Article

NeuroMetrix announces allowance for patents for Quell Wearable Pain Relief Technology features
Monday, 8 May 2017 11:04am EDT 

May 8 (Reuters) - NeuroMetrix Inc ::Notices of Allowance issued for patents covering key features of Quell Wearable Pain Relief Technology by European Patent Office.Expects the three Quell Wearable Pain Relief Technology patents to formally issue by Q3 of 2017.Notices of Allowance has been issued also by Japan Patent Office, and State Intellectual Property Office of People's Republic of China.  Full Article

NeuroMetrix Q1 loss per share $0.91
Thursday, 20 Apr 2017 07:00am EDT 

April 20 (Reuters) - NeuroMetrix Inc :NeuroMetrix reports Q1 2017 financial results.Q1 revenue rose 89 percent to $4.3 million.Q1 loss per share $0.91.  Full Article

Neurometrix Q4 loss per share $0.52
Thursday, 26 Jan 2017 07:00am EST 

Neurometrix Inc : Neurometrix reports Q4 and full year 2016 financial results . Q4 revenue rose 36 percent to $3.7 million .Q4 loss per share $0.52.  Full Article

Neurometrix- in talks for partnerships for quell wearable pain relief technology
Tuesday, 16 Aug 2016 07:00am EDT 

Neurometrix Inc : Neurometrix commentary on strategic and business partnerships for quell wearable pain relief technology . Says is currently engaged in discussions around several types of partnerships including an e-commerce collaboration in US market .Also currently engaged in discussions around several types of partnerships for licensing, distribution rights to European, Asian markets, research and development.  Full Article

Neurometrix reports Q2 loss per share of $5.37
Thursday, 21 Jul 2016 07:00am EDT 

Neurometrix Inc : Neurometrix reports q2 2016 financial results and highlights . Neurometrix reports q2 2016 financial results and highlights . Q2 loss per share $5.37 . Q2 revenue rose 116 percent to $2.65 million .Q2 earnings per share view $-0.93, revenue view $2.7 million -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-NeuroMetrix CFO reports purchase of 2,500 shares of co's common stock on Oct 23 at $1.77 per share

* NeuroMetrix Inc CFO Thomas​ ‍Higgins reports purchase of 2,500 shares of co's common stock on Oct 23 at $1.77 per share - sec filing Source text (http://bit.ly/2gBQZj2) Further company coverage: